The prevention and management of outbreaks and epidemics like COVID-19 and other emerging infectious illnesses emphasize the critical importance of vaccinations and quick vaccine development.
Vaccination is one of the most cost-efficient and effective public health strategies for infectious disease prevention and control, as well as one of the most successful ways to prevent the spread of infectious pathogens on a wide scale. However, developing a vaccine is a lengthy, complex, and costly procedure.
This white paper from ERS Genomics describes applications for CRISPR-Cas9 systems in accelerating vaccine research and development.
Offered Free by: ERS Genomics
See All Resources from: ERS Genomics
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.